低分子量小分子はRNAを強力に結合し,細胞内の腫瘍発生経路に影響を与える
Blessy M Suresh1, Yoshihiro Akahori1, Amirhossein Taghavi1
1Department of Chemistry, The Scripps Research Institute & UF Scripps Biomedical Research, 130 Scripps Way, Jupiter, Florida 33458, United States.
Journal of the American Chemical Society
|November 2, 2022
まとめ
研究者は新しいプラットフォームと 大きな断片ライブラリを開発し RNAを小さな分子でターゲットにしました 薬のような断片が特定され,マイクロRNA-372の処理を強力に阻害し,胃がん細胞の表型を減少させた.
科学分野:
- 生物化学
- 分子生物学
- 薬剤化学
背景:
- RNAを小さな分子,特に低分子量分子で標的にすることは,十分な親和性と特異性を達成する上で重要な課題を提示します.
- RNAとの新しい生物活性相互作用の開発は,治療の進歩にとって極めて重要です.
研究 の 目的:
- RNAを効果的に標的にできる小さな分子を特定するためのプラットフォームを開発する.
- 特定のRNAの調節を可能にする新しい生物活性断片を発見し,特徴づけること.
主な方法:
- 2500組のRNAを中心とした小分子断片の収集.
- RNA ライブラリに対するライブラリ対ライブラリ選択を用いて,1280万件以上の断片-RNAの相互作用を調査した.
- 薬のような断片を特定するために ヒトのトランスクリプトームの相互作用データを採取します
主要な成果:
- マイクロRNA-372のヘアピン前駆体に対する強力な特異的標的を持つ薬のような断片の特定.
- 胃がん細胞におけるマイクロRNA処理の抑制と腫瘍性フェノタイプの緩和の実証
- 断片の好ましい性質の特徴: 300 ± 130 nMの親和度, 273 Daの分子量, 0.8のQEDスコア.
結論:
- 低分子量で断片状の化合物は,RNA標的を特異的かつ強力に調節することができます.
- 開発されたプラットフォームは,新しいRNA標的生物活性分子の発見を可能にします.
- このアプローチは,特定のRNAターゲットを伴う病気に対する新しい治療法の開発に期待されます.
関連する概念動画
Types of RNA
64.4K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
64.4K
RNA Interference
26.3K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.3K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Regulation of Expression at Multiple Steps
976
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
976
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
lncRNA - Long Non-coding RNAs
8.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.8K


